Clinical Trial Update: Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effect of Angeliq on blood pressure in postmenopausal hypertensive women; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• ANGELIQ (DROSPIRENONE AND ESTRADIOL)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Postmenopause | Phase 3 | Status: COMPLETED